LongeVC — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Catena Biosciencescatenabio.com inMay 2024 · $2.4M

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen

Co-investorsCalifornia Innovation Fund Civilization Ventures Management, Llc Creative Destruction Lab (CDL)FREEFLOW Gaingels Iaso Ventures +14 more

Glyphic Biotechnologiesglyphic.bio in 𝕏Feb 2024

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)

BoardCraig Asher(Director)inJimmy Yun(Director)in

Co-investorsArtis Ventures Black Flag Civilization Ventures Management, Llc FoundersX Ventures Gaingels Harpoon Ventures +10 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.